期刊文献+

脂联素及其受体2mRNA在非酒精性脂肪性肝炎大鼠的表达及替米沙坦的干预作用

The expression of adiponectin and adiponectin receptor R2 mRNA in rats with nonalcoholic steatohepatitis and the intervention effects of telmisartan on it
下载PDF
导出
摘要 目的探讨替米沙坦对非酒精性脂肪性肝炎(NASH)大鼠肝组织脂联素及其受体R2mRNA表达的影响。方法 35只雄性SD大鼠随机分为正常对照组(NC组,n=10)、模型组(FC组,n=15)和替米沙坦干预组(FT组,n=10)。FC和FT组给予高脂饲料喂养16周诱发脂肪性肝炎,其中FT组于高脂喂养12周后,给予替米沙坦(5mg·kg-1·d-1)灌胃治疗4周。取肝组织测肝指数;检测血清ALT及AST,RT-PCR方法测定大鼠肝组织脂联素及其受体R2mRNA的表达。结果与NC组相比,FC组血清ALT、AST均明显升高(P<0.01),脂联素及其受体R2mRNA水平均显著降低(P<0.01);FT组的血清ALT显著降低(P<0.01),脂联素及其受体R2mRNA水平较FC组均升高(P<0.05)。结论替米沙坦对实验性非酒精性脂肪肝大鼠具有一定的治疗作用,其作用机制之一是促进肝脏脂联素及其受体R2mRNA的表达。 Objective To investigate the effects of telmisartan on the expression of adiponectin and adiponectin receptor R2 mRNA in rats with nonalcoholic steatohepatitis (NASH). Methods 35 male SD rats were randomly divided into normal control group(NC group, n = 10),NASH model group( FC group, n = 15) and telmisartan intervention group( FT group, n = 10). The rats in NC group were given standard diet,however,the rats in the other two groups were given high fat diet for 16 weeks to induce NASH. After 12 weeks the rats in FT group were given telmisartan (Stag · kg-1 · d-1 ) for 4 weeks by gavage. At the end of the 16th week,all the animals were sacrificed and the rat's body weight was recorded,liver indexes were determined,the levels of ALT and AST in serum were detected by using automatic biochemistry analyzer, and the expressions of adiponeetin and adiponectin receptor 1t2 mRNA in liver tissue were detected by RT-PCR. Results As compared with those in NC group,the levels of serum ALT and AST were significantly increased in FC group ( P 〈 0.01 ), however, the expressions of adiponectin and adiponectin receptor R2 mRNA in liver tissue were significantly decreased in FC group ( P 〈0.01 ). As compared with those in FC group,the levels of serum ALT was obviously decreased in Ft group ( P 〈0.01 ), however, the levels of adiponectin and adiponectin receptor R2 mRNA in liver tissue were significantly higher than those in FT group ( P 〈 0.05). Conclusion Telmisartan is effective in treating rats with NASH,and one of the action mechanisms is that telmisartan can promote the expression of adiponectin and adiponectin receptor R2 mRNA in liver.
机构地区 华北石油总医院
出处 《河北医药》 CAS 2012年第2期167-169,共3页 Hebei Medical Journal
关键词 非酒精性脂肪性肝炎 替米沙坦 脂联素 脂联素受体2 nonalcoholic steatohepatitis telmisartan adiponectin adiponectin receptor R2
  • 相关文献

参考文献13

  • 1Abbasi F, Chu JW, Lamendola C, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes, 2004,53:585-590.
  • 2Vuppalanehi R, Marri S, Kolwankar D, et al. Is adiponeetin involved in the Pathogenesis of nonalcoholic steatohepatitis A preliminary human study. J Clin Gastroenteml,2005 ,39 :237-242.
  • 3Krawezyk K, Szczcsniak P, Kumor A, et al. Adipohormones as prognostric markers in patients with nonaleoholie steatohepatitis (NASH). J Physiol Pharmaeo1,2009, Suppl 3:71-75.
  • 4Shimabukum M, Tanaka H, Shimabukum T. Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. Journal of Hypertension ,2007,25:841-848.
  • 5Yamada S, Ano N, Toda K, et al. Telmisartan but not eandesartan affects adiponectin expression in vivo and in vitro. Hypertens Res,2008,31: 601-606.
  • 6Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology,2005 ,42 :641-649.
  • 7Varela-Rey M, Embade N, Ariz U, et al. Martinez-Chantar ML. Non-alco- holic steatohepatitis and animal models: understanding the human disease. Int J Bioehem Cell Biol,2009,41:969-976.
  • 8Nishimura S, Manabe I, Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome. Diseov Med ,2009,8:55-60.
  • 9Xu A, Keshaw H, Keshaw H, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest ,2003,112:91-100.
  • 10Yalniz M, Bahceeioglu IH, Ataseven H, et al. Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis. Mediators Inflamm, 2006, 2006,34 : 295.

二级参考文献11

  • 1庞敏,冯丽英.脂联素在非酒精性脂肪肝病中的作用[J].中国全科医学,2008,11(24):2277-2279. 被引量:4
  • 2刘利梅,赵亚莉,李丽,吴立玲.脂联素的信号转导通路[J].生理科学进展,2005,36(2):130-132. 被引量:18
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 4杨辉,李瑜元,聂玉强,周永健,杜艳蕾,沙卫红,洪勇.非酒精性脂肪肝患者胰岛素抵抗与脂联素基因表达的关系[J].中华肝脏病杂志,2007,15(7):525-528. 被引量:15
  • 5Kleiner DE,Brunt EM,Van Natta M,et al.Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology,2005,41:1313-1321.
  • 6Yamauchi T,Kamon J,Minokoshi Y,et al.Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.Nat Med,2002,8:1288-1295.
  • 7Ouchi N,Walsh K.Adiponectin as an anti-inflammatory factor.Clin Chim Acta,2007,380:24-30.
  • 8Yokota T,Oritani K,Takahashi I,et al.Adiponectin,a new member of the family of soluble defense collagens,negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.Blood,2002,96:1723-1732.
  • 9Kamada Y,Tamura S,Kiso S,et al.Enhanced carbontetrachloride-induced liver fibrosis in mice lacking adiponectin.Gastroenterology,2003,125:1796-1807.
  • 10Ding X,Saxena NK,Lin S,et al.The roles of leptin and adiponectin:a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cellbiology.Am J Pathol,2005,166:1655-1669.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部